» Articles » PMID: 16709565

The Brichos Domain-containing C-terminal Part of Pro-surfactant Protein C Binds to an Unfolded Poly-val Transmembrane Segment

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 May 20
PMID 16709565
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Native lung surfactant protein C (SP-C) is a 4.2-kDa acylpeptide that associates with alveolar surfactant phospholipids via a transmembrane alpha-helix. This helix contains mainly Val, although poly-Val is inefficient in helix formation, and helical SP-C can spontaneously convert to beta-sheet aggregates and amyloid-like fibrils. SP-C is cleaved out from a 21-kDa integral membrane protein, proSP-C, in the alveolar type II cell. Recently several mutations localized in the endoplasmic reticulum-lumenal (C-terminal) part of proSP-C (CTproSP-C) have been associated with intracellular accumulation of toxic forms of proSP-C, low levels of mature SP-C, and development of interstitial lung disease. CTproSP-C contains a approximately 100-residue Brichos domain of unknown function that is also found in other membrane proteins associated with amyloid formation, dementia, and cancer. Here we find that recombinant CTproSP-C binds lipid-associated SP-C, which is in beta-strand conformation, and that this interaction results in an increased helical content. In contrast, CTproSP-C does not bind alpha-helical SP-C. Recombinant CTproSP-C(L188Q), a mutation associated with interstitial lung disease, shows secondary and quaternary structures similar to those of wild type CTproSP-C but is unable to bind lipid-associated beta-strand SP-C. Transfection of CTproSP-C into HEK293 cells that express proSP-C(L188Q) increases the amount of proSP-C protein, whereas no effect is seen on cells expressing wild type proSP-C. These findings suggest that CTproSP-C binds nonhelical SP-C and thereby prevents beta-sheet aggregation and that mutations in CTproSP-C can interfere with this function.

Citing Articles

A new kid in the folding funnel: Molecular chaperone activities of the BRICHOS domain.

Leppert A, Poska H, Landreh M, Abelein A, Chen G, Johansson J Protein Sci. 2023; 32(6):e4645.

PMID: 37096906 PMC: 10182729. DOI: 10.1002/pro.4645.


OAF: a new member of the BRICHOS family.

Sanchez-Pulido L, Ponting C Bioinform Adv. 2023; 2(1):vbac087.

PMID: 36699367 PMC: 9714404. DOI: 10.1093/bioadv/vbac087.


Gene Therapeutics for Surfactant Dysfunction Disorders: Targeting the Alveolar Type 2 Epithelial Cell.

Sitaraman S, Alysandratos K, Wambach J, Limberis M Hum Gene Ther. 2022; 33(19-20):1011-1022.

PMID: 36166236 PMC: 9595619. DOI: 10.1089/hum.2022.130.


Mapping SP-C co-chaperone binding sites reveals molecular consequences of disease-causing mutations on protein maturation.

Pobre-Piza K, Mann M, Flory A, Hendershot L Nat Commun. 2022; 13(1):1821.

PMID: 35383173 PMC: 8983781. DOI: 10.1038/s41467-022-29478-z.


Endogenous Human Proteins Interfering with Amyloid Formation.

Gharibyan A, Jayaweera S, Lehmann M, Anan I, Olofsson A Biomolecules. 2022; 12(3).

PMID: 35327638 PMC: 8946693. DOI: 10.3390/biom12030446.